secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-05-14T12:30:25+00:00
Accession:  0001493152-26-022886
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical records first revenue from LIBERTY; Q2 revenue already exceeds Q1
--------------------------------------------------------------------------------

- Recorded revenue from limited market release of LIBERTY System in Q1 2026; transitioned to full market release in Q2.
- Q2 revenue mid-way through quarter already exceeds total Q1 revenue; accounts more than doubled since LMR ended.
- Hospitals in six states (GA, FL, NY, MI, MA, NC) have adopted the system; Boston now has multiple accounts.
- First robotic procedures include PAE for BPH, GAE for knee pain, and Y-90 radioembolization for liver cancer.
- Growth supported by updated occupational radiation guidelines from nine medical societies including AMA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226022886/0001493152-26-022886-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226022886/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-022886

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer